Language selection

Search

Canada's Access to Medicines Regime background In August 2003, negotiations among World Trade Organization (WTO) members resulted in a landmark decision to waive two licensing provisions of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) that appeared to prevent the export of generic drugs and medical devices to developing countries faced with public health problems. 2020-09-17 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCanada's Access to Medicines RegimeWorld Trade Organizationwaive licensing provisionsWTO AgreementIntellectual Property Rightsdeveloping and least-developed countriesimport high-quality drugs and medical devices Canada's Access to Medicines Regime backgroundHTML https://www.canada.ca/en/health-canada/services/canada-access-medicines-regime/introduction/background.html Canada's Access to Medicines Regime backgroundHTML https://www.canada.ca/fr/sante-canada/services/regime-canadien-acces-medicaments/introduction/contexte.html

Canada's Access to Medicines Regime background

In August 2003, negotiations among World Trade Organization (WTO) members resulted in a landmark decision to waive two licensing provisions of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) that appeared to prevent the export of generic drugs and medical devices to developing countries faced with public health problems.

Resources

Resource Name Resource Type Format Language Links
Canada's Access to Medicines Regime background Publication HTML English Access
Canada's Access to Medicines Regime background Publication HTML French Access
Similar records